The Ombu Library has analysis and recommendations of a Warning Letter involving failure to properly assign an auditor as required by 820.22. In this Warning Letter, a firm didn’t follow its own procedure and assigned an auditor to an area for which the auditor had direct responsibility. The firm responded, but the FDA concluded that the response was not adequate.